|SEQ_NO||1||Date of announcement||2021/04/14||Time of announcement||16:37:23|
|Subject||Announcement of TTY Biopharm's unaudited income information in March 2021|
|Date of events||2021/04/14||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2021/04/14
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $322,718 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $64,286 thousands, and a consolidated income before tax of $89,463 thousands in March 2021; net income attributed to stockholders of the company was $72,629 thousands; EPS is $0.29.
Year-to-date consolidated net sales was $964,056 thousands (in NT dollars; unaudited), a consolidated operating profit was $219,158 thousands and consolidated income before tax was $254,325 thousands until March 2021; year-to-date net income attributed to stockholders of the company was $204,425 thousands; EPS is $0.82.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.